Molecular Diagnosis in 100% of Dystrophinopathies
Are We There Yet?
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published January 29, 2021.
Author Disclosures
- Elena Pegoraro, MD, PhD
- Elena Pegoraro, MD, PhD
PTC Pharmaceuticals, commercial entity Sarepta, commercial entity Santhera, commercial entity Genzyme, commercial entity Roche, commercial entity Biogen, commercial entity
NONE
Received funding for travel and educational support from Genzyme. Received funding for travel support from Santhera.
Serving as editorial advisory board member of Acta Myologica
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Received institutional support from the University of Padova
Cariparo Foundation Padova Italy, University of Padova
NONE
NONE
NONE
NONE
NONE
NONE
- From the ERN Neuromuscular Unit, Department of Neurosciences, DNS, University of Padova, Padova, Italy.
- Correspondence
Dr. Pegoraro elena.pegoraro{at}unipd.it
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
WGS and RNA Studies Diagnose Noncoding DMD Variants in Males With High Creatine KinaseLeigh B. Waddell, Samantha J. Bryen, Beryl B. Cummings et al.Neurology: Genetics, January 29, 2021 -
Articles
Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophyEvidence for failure of dystrophin production in dystrophin-competent myonucleiE. Pegoraro, R. N. Schimke, C. Garcia et al.Neurology, April 01, 1995 -
ARTICLES
Cognitive dysfunction as the major presenting feature of Becker's muscular dystrophyK. N. North, G. Miller, S. T. Iannaccone et al.Neurology, February 01, 1996 -
Article
Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophyDiane E. Frank, Frederick J. Schnell, Cody Akana et al.Neurology, March 05, 2020